Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Article numbere0164862
JournalPLOS ONE
Volume11
Issue number11
DOIs
Publication statusPublished - 3 Nov 2016

Cite this

@article{95bc35b5eb98470abc427f197a69af48,
title = "Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling",
author = "Kremer, {Ingrid E. H.} and Evers, {Silvia M. A. A.} and Jongen, {Peter J.} and {van der Weijden}, Trudy and {van de Kolk}, Ilona and Mickael Hiligsmann",
year = "2016",
month = "11",
day = "3",
doi = "10.1371/journal.pone.0164862",
language = "English",
volume = "11",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

AU - Kremer, Ingrid E. H.

AU - Evers, Silvia M. A. A.

AU - Jongen, Peter J.

AU - van der Weijden, Trudy

AU - van de Kolk, Ilona

AU - Hiligsmann, Mickael

PY - 2016/11/3

Y1 - 2016/11/3

U2 - 10.1371/journal.pone.0164862

DO - 10.1371/journal.pone.0164862

M3 - Article

VL - 11

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 11

M1 - e0164862

ER -